Pressure Biosciences Inc financial data

Symbol
PBIO on OTC
Industry
Laboratory Analytical Instruments
Location
480 Neponset St., Canton, MA
State of incorporation
MA
Fiscal year end
December 31
Former names
BOSTON BIOMEDICA INC (to 9/2/2004)
Latest financial report
10-Q - Q2 2024 - Feb 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.38 % -48%
Quick Ratio 1.26 % -51.2%
Debt-to-equity -112 % -4.47%
Return On Equity 24.2 % -68%
Return On Assets -200 % +80.7%
Operating Margin -381 % -55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41M shares
Common Stock, Shares, Outstanding 54M shares +176%
Entity Public Float 8M USD
Common Stock, Value, Issued 540K USD +176%
Weighted Average Number of Shares Outstanding, Basic 51.4M shares +164%
Weighted Average Number of Shares Outstanding, Diluted 51.4M shares +164%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2M USD +10.6%
Revenue from Contract with Customer, Excluding Assessed Tax 1.5M USD -25.3%
Research and Development Expense 1.22M USD -0.98%
Selling and Marketing Expense 638K USD +8.91%
General and Administrative Expense 6.66M USD +14.8%
Costs and Expenses 9.69M USD +0.63%
Operating Income (Loss) -8.2M USD -7.44%
Nonoperating Income (Expense) -22.5M USD -49.5%
Net Income (Loss) Attributable to Parent -8.27M USD +63.6%
Earnings Per Share, Basic -0.85 USD/shares +53.8%
Earnings Per Share, Diluted -0.85 USD/shares +73.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.3K USD -42.9%
Accounts Receivable, after Allowance for Credit Loss, Current 184K USD -2.66%
Inventory, Net 542K USD -2.12%
Assets, Current 874K USD -16.7%
Property, Plant and Equipment, Net 72K USD -22.9%
Operating Lease, Right-of-Use Asset 582K USD +231%
Intangible Assets, Net (Excluding Goodwill) 513K USD +87.3%
Goodwill 4.77M USD
Assets 6.88M USD +311%
Accounts Payable, Current 2.49M USD +173%
Employee-related Liabilities, Current 444K USD +54%
Liabilities, Current 43.6M USD +64.2%
Operating Lease, Liability, Noncurrent 359K USD +344%
Liabilities 44.1M USD +64.6%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 100 USD -90.9%
Retained Earnings (Accumulated Deficit) -186M USD -22.3%
Stockholders' Equity Attributable to Parent -37.2M USD -48.2%
Liabilities and Equity 6.88M USD +311%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.86M USD -340%
Net Cash Provided by (Used in) Financing Activities 1.78M USD +170%
Net Cash Provided by (Used in) Investing Activities -3K USD -164%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 54M shares +176%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -78.1K USD -133%
Interest Paid, Excluding Capitalized Interest, Operating Activities 325K USD -39.3%
Deferred Tax Assets, Valuation Allowance 40.6M USD +25.3%
Operating Lease, Liability 566K USD +286%
Payments to Acquire Property, Plant, and Equipment 3K USD +164%
Lessee, Operating Lease, Liability, to be Paid 932K USD +261%
Property, Plant and Equipment, Gross 655K USD +1.16%
Operating Lease, Liability, Current 208K USD +216%
Lessee, Operating Lease, Liability, to be Paid, Year Two 204K USD +204%
Lessee, Operating Lease, Liability, to be Paid, Year One 212K USD +229%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 366K USD +228%
Lessee, Operating Lease, Liability, to be Paid, Year Three 158K USD +205%
Deferred Tax Assets, Operating Loss Carryforwards 36.3M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 164K USD
Operating Lease, Payments 48.6K USD -46.2%
Additional Paid in Capital 113M USD +23.3%
Share-based Payment Arrangement, Expense 2.41M USD
Interest Expense 15.6M USD +49.3%